FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer - United States
doi 10.1002/cncr.25908
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Evolving Role of FLT3 Inhibitors in Acute Myeloid Leukemia: Quizartinib and Beyond

Therapeutic Advances in Hematology
Hematology
2014English

Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2015English

FLT3 Inhibitors in Acute Myeloid Leukemia: Choosing the Best When the Optimal Does Not Exist

American Journal of Hematology
Hematology
2018English

FLT3-TKD Mutation in Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

CDK9 Inhibitors in Acute Myeloid Leukemia

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2019English

DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia

Haematologica
Hematology
2019English

Differential Signaling of Flt3 Activating Mutations in Acute Myeloid Leukemia: A Working Model

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2011English

Novel Mutations in the FLT3 Gene in Adult Patients With Refractory Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy